Intrauterine growth retardation after long-term maternal salicylate administration in the rabbit

Jeffrey C. Lukas, Ted S. Rosenkrantz, John R. Raye, Patricia J. Porte, Anthony F Philipps

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The effects of chronic maternal salicylism on fetal growth were studied in chronically catheterized pregnant rabbits. Graded intravenous infusions of sodium salicylate were given continuously between days 22 and 29 of gestation. Maternal plasma salicylate concentrations (mean ± SD) of 12.0 ± 1.6 mg/dl (low-dose group) or 24.1 ± 5.3 mg/dl (high-dose group) were achieved. Control rabbits were infused with saline solution. Pups were delivered by hysterotomy on day 29. Fetal/matermal salicylate concentration ratios were near unity for both infusion groups. There were significant dose-related reductions (mean ± SD) in fetal weight (control, 39.7 ± 6.7 gm; low-dose group, 34.4 ± 6.4 gm; high-dose group, 22.2 ± 7.1 gm; p < 0.001) and in crown-rump length (control, 9.7 ± 0.45 cm; low-dose group, 9.1 ± 0.68 cm; high-dose group, 7.7 ± 0.86 cm; p < 0.001). There was a significant reduction in fetal brain weight only in the high-dose group, and brain weight/fetal weight ratios were increased, suggesting relative sparing of brain growth. Liver weight was significantly reduced in both low- and high-dose groups. In contrast to results in previous animal studies, standardized intravenous maternal salicylate administration in rabbits induced a reproducible and dose-dependent asymmetrical fetal growth retardation.

Original languageEnglish (US)
Pages (from-to)245-249
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume156
Issue number1
DOIs
StatePublished - 1987
Externally publishedYes

Fingerprint

Fetal Weight
Fetal Growth Retardation
Salicylates
Mothers
Rabbits
Brain
Hysterotomy
Sodium Salicylate
Crown-Rump Length
Weights and Measures
Fetal Development
Intravenous Infusions
Sodium Chloride
Pregnancy
Liver
Growth

Keywords

  • fetal
  • growth
  • intrauterine growth retardation
  • maternal
  • Salicylates

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Intrauterine growth retardation after long-term maternal salicylate administration in the rabbit. / Lukas, Jeffrey C.; Rosenkrantz, Ted S.; Raye, John R.; Porte, Patricia J.; Philipps, Anthony F.

In: American Journal of Obstetrics and Gynecology, Vol. 156, No. 1, 1987, p. 245-249.

Research output: Contribution to journalArticle

Lukas, Jeffrey C. ; Rosenkrantz, Ted S. ; Raye, John R. ; Porte, Patricia J. ; Philipps, Anthony F. / Intrauterine growth retardation after long-term maternal salicylate administration in the rabbit. In: American Journal of Obstetrics and Gynecology. 1987 ; Vol. 156, No. 1. pp. 245-249.
@article{a199eec565754a37849d32f0b555b800,
title = "Intrauterine growth retardation after long-term maternal salicylate administration in the rabbit",
abstract = "The effects of chronic maternal salicylism on fetal growth were studied in chronically catheterized pregnant rabbits. Graded intravenous infusions of sodium salicylate were given continuously between days 22 and 29 of gestation. Maternal plasma salicylate concentrations (mean ± SD) of 12.0 ± 1.6 mg/dl (low-dose group) or 24.1 ± 5.3 mg/dl (high-dose group) were achieved. Control rabbits were infused with saline solution. Pups were delivered by hysterotomy on day 29. Fetal/matermal salicylate concentration ratios were near unity for both infusion groups. There were significant dose-related reductions (mean ± SD) in fetal weight (control, 39.7 ± 6.7 gm; low-dose group, 34.4 ± 6.4 gm; high-dose group, 22.2 ± 7.1 gm; p < 0.001) and in crown-rump length (control, 9.7 ± 0.45 cm; low-dose group, 9.1 ± 0.68 cm; high-dose group, 7.7 ± 0.86 cm; p < 0.001). There was a significant reduction in fetal brain weight only in the high-dose group, and brain weight/fetal weight ratios were increased, suggesting relative sparing of brain growth. Liver weight was significantly reduced in both low- and high-dose groups. In contrast to results in previous animal studies, standardized intravenous maternal salicylate administration in rabbits induced a reproducible and dose-dependent asymmetrical fetal growth retardation.",
keywords = "fetal, growth, intrauterine growth retardation, maternal, Salicylates",
author = "Lukas, {Jeffrey C.} and Rosenkrantz, {Ted S.} and Raye, {John R.} and Porte, {Patricia J.} and Philipps, {Anthony F}",
year = "1987",
doi = "10.1016/0002-9378(87)90246-8",
language = "English (US)",
volume = "156",
pages = "245--249",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Intrauterine growth retardation after long-term maternal salicylate administration in the rabbit

AU - Lukas, Jeffrey C.

AU - Rosenkrantz, Ted S.

AU - Raye, John R.

AU - Porte, Patricia J.

AU - Philipps, Anthony F

PY - 1987

Y1 - 1987

N2 - The effects of chronic maternal salicylism on fetal growth were studied in chronically catheterized pregnant rabbits. Graded intravenous infusions of sodium salicylate were given continuously between days 22 and 29 of gestation. Maternal plasma salicylate concentrations (mean ± SD) of 12.0 ± 1.6 mg/dl (low-dose group) or 24.1 ± 5.3 mg/dl (high-dose group) were achieved. Control rabbits were infused with saline solution. Pups were delivered by hysterotomy on day 29. Fetal/matermal salicylate concentration ratios were near unity for both infusion groups. There were significant dose-related reductions (mean ± SD) in fetal weight (control, 39.7 ± 6.7 gm; low-dose group, 34.4 ± 6.4 gm; high-dose group, 22.2 ± 7.1 gm; p < 0.001) and in crown-rump length (control, 9.7 ± 0.45 cm; low-dose group, 9.1 ± 0.68 cm; high-dose group, 7.7 ± 0.86 cm; p < 0.001). There was a significant reduction in fetal brain weight only in the high-dose group, and brain weight/fetal weight ratios were increased, suggesting relative sparing of brain growth. Liver weight was significantly reduced in both low- and high-dose groups. In contrast to results in previous animal studies, standardized intravenous maternal salicylate administration in rabbits induced a reproducible and dose-dependent asymmetrical fetal growth retardation.

AB - The effects of chronic maternal salicylism on fetal growth were studied in chronically catheterized pregnant rabbits. Graded intravenous infusions of sodium salicylate were given continuously between days 22 and 29 of gestation. Maternal plasma salicylate concentrations (mean ± SD) of 12.0 ± 1.6 mg/dl (low-dose group) or 24.1 ± 5.3 mg/dl (high-dose group) were achieved. Control rabbits were infused with saline solution. Pups were delivered by hysterotomy on day 29. Fetal/matermal salicylate concentration ratios were near unity for both infusion groups. There were significant dose-related reductions (mean ± SD) in fetal weight (control, 39.7 ± 6.7 gm; low-dose group, 34.4 ± 6.4 gm; high-dose group, 22.2 ± 7.1 gm; p < 0.001) and in crown-rump length (control, 9.7 ± 0.45 cm; low-dose group, 9.1 ± 0.68 cm; high-dose group, 7.7 ± 0.86 cm; p < 0.001). There was a significant reduction in fetal brain weight only in the high-dose group, and brain weight/fetal weight ratios were increased, suggesting relative sparing of brain growth. Liver weight was significantly reduced in both low- and high-dose groups. In contrast to results in previous animal studies, standardized intravenous maternal salicylate administration in rabbits induced a reproducible and dose-dependent asymmetrical fetal growth retardation.

KW - fetal

KW - growth

KW - intrauterine growth retardation

KW - maternal

KW - Salicylates

UR - http://www.scopus.com/inward/record.url?scp=0023115581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023115581&partnerID=8YFLogxK

U2 - 10.1016/0002-9378(87)90246-8

DO - 10.1016/0002-9378(87)90246-8

M3 - Article

VL - 156

SP - 245

EP - 249

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1

ER -